PerkinElmer, Shelton, CT-based analytical services and solutions provider, acquired Covaris, a Woburn, MA-based developer of solutions to empower life science innovations.
The amount of the deal was not disclosed.
The merger will accelerate Covaris’ growth potential and expand PerkinElmer’s existing life sciences portfolio into the high-growth diagnostics end market. Both companies are majority owned by New Mountain Capital.
Founded in 1999 and led by Annemarie Watson, CEO, Covaris develops, manufactures, and markets instruments, consumables, and reagents used in pre-analytical sample preparation for genomic and proteomic analysis to help accelerate the pace of research and life science innovations. Using proprietary technologies including focused acoustic energy, Covaris’ tools achieve accurate and reproducible results with the goal of empowering customers to make new discoveries, develop new assays and improve bioanalytical results. Some of the non-contact applications include faster automated DNA fragmentation, cell lysis, accelerated binding partner mixing, bead resuspension, and compound formulation.
Led by Dirk Bontridder, CEO, PerkinElmer is a global analytical services and solutions provider with offerings including the OneSource Field and Laboratory services business that serve the biopharma, food, environmental, safety and applied end markets to accelerate scientific outcomes. Since 1937, it has served as a partner in laboratory analysis and management and today complements its service offerings with a broad portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents.
With a dedicated team of more than 6,000 team members, the company serves customers in more than 35 countries.
FinSMEs
04/12/2023